Home >> Tag Archives: Memorial Sloan Kettering Cancer Center

Tag Archives: Memorial Sloan Kettering Cancer Center

MSK-ACCESS gets New York State approval

November 2019—Memorial Sloan Kettering Cancer Center announced that the New York State Department of Health has issued an approval for its Analysis of Circulating cfDNA to Evaluate Somatic Status (MSK-ACCESS) molecular assay. MSK-ACCESS was developed in the Marie-Josée and Henry R. Kravis Center for Molecular Oncology and has been clinically validated and implemented by members of MSK’s molecular diagnostics service.

Read More »
CAP TODAY
X